Martin, L. P., Sill, M., Shahin, M. S., Powell, M., DiSilvestro, P., Landrum, L. M., . . . Schilder, R. J. (2013). A Phase II Evaluation of AMG 102 (Rilotumumab) In The Treatment Of Persistent Or Recurrent Epithelial Ovarian, Fallopian Tube Or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study. Gynecol Oncol.
Chicago Style citaatMartin, Lainie P., et al. "A Phase II Evaluation of AMG 102 (Rilotumumab) In The Treatment Of Persistent Or Recurrent Epithelial Ovarian, Fallopian Tube Or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study." Gynecol Oncol 2013.
MLA citatieMartin, Lainie P., et al. "A Phase II Evaluation of AMG 102 (Rilotumumab) In The Treatment Of Persistent Or Recurrent Epithelial Ovarian, Fallopian Tube Or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study." Gynecol Oncol 2013.